Fusion constructs containing active sections on TNF ligands
Disclosed is a recombinant fusion protein containing an amino-acid sequence which comprises: (a) the Fc section or part of an Fc section of an immunoglobulin as component (A) or a functional variant of component (A); (b) the extracellular part of a TNF ligand or a partial sequence of the extracellular part of a TNF ligand as component (B) or a functional variant of component (B); and optionally (c) a transition area between component (A) and component (B), containing a linker.
1. A recombinant fusion protein which contains an amino acid sequence which comprises: (a) an Fc segment of an immunoglobulin, wherein the Fc segment consists of amino acids 18 to 243 of SEQ ID NO: 6, as component (A), and (b) an extracellular moiety of EDA1, as component (B), wherein component (B) comprises amino acids 266 to 412 of SEQ ID NO: 6.
2. The recombinant fusion protein as claimed in claim 1 , wherein the recombinant fusion protein has the amino acid sequence of SEQ ID NO: 6.
3. A composition comprising a recombinant fusion protein as claimed in claim 1 and a pharmaceutically acceptable carrier material.
4. A DNA sequence, encoding a recombinant fusion protein as claimed in claim 1 .
5. An expression vector, wherein the expression vector contains a DNA sequence as claimed in claim 4 .
6. An isolated host cell transfected with the expression vector as claimed in claim 5 .
7. A hexamer of a recombinant fusion protein comprising six chains of the recombinant fusion protein, wherein said fusion protein comprises an amino acid sequence which comprises:
(a) an Fc segment, of an immunoglobulin, wherein the Fc segment consists of amino acids 18 to 243 of SEQ ID NO: 6, as component (A), and
(b) the extracellular moiety of EDA1, as component (B), wherein component (B) comprises the amino acid sequence of amino acids 266 to 412 of SEQ ID NO: 6.
8. The hexamer of claim 7 , wherein the recombinant fusion protein has the amino acid sequence of SEQ ID NO: 6.